On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queens . . .
2022.06.08We have formed a business alliance with Sojitz Corporation.→PRESS RELEASE
2022.03.11We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare pr . . .
2022.03.11We are pleased to announce that we have issued new shares to Aioi Nissay Dowa Insurance Co. through third party allocation. Both companies are l . . .
2022.02.02Our nematode cancer test “N-NOSE” is now available on Amazon. →Click here to visit our Amazon store.
2022.01.19Hirotsu Bio Science has completed its third-party allocation to Kurume Research Park, a semi-public sector company funded by Fukuoka Prefecture . . .
2022.01.17HIROTSU BIO SCIENCE INC. recently increased its capital through the allocation of new shares to third parties. To deliver N-NOSE, a new method . . .
2021.12.28Several overseas research institutes have conducted “replication studies” using N-NOSE, the world’s first biological screening technology, focus . . .
2021.12.13We are pleased to announce that Hirotsu Bio Science was ranked the 6th in the "NEXT Unicorn Survey" run by Nikkei Inc. for 2021.
2021.12.12HIROTSU BIO SCIENCE INC. has joined forces with Sumitomo Mitsui Trust Club Co., Ltd., the issuer of the Diners Club cards, to provide special di . . .
2021.11.24Several overseas research institutes have conducted “replication studies” using N-NOSE, the world’s first biological screening technology, focus . . .
2021.11.08We will open the first sample collection base in Shikoku, "N-NOSE Station MATSUYAMA" in Matsuyama Mitsukoshi, and will start accepting samples f . . .
2021.11.02